Paper30856464
Sulforaphane triggers a functional elongation of microglial process via the Akt signal.
Wu Y and 8 others. J Nutr Biochem, 2019. Cited by 11 papers, by iCite.
Cite this record
ConductScience Library. Sulforaphane triggers a functional elongation of microglial process via the Akt signal. Papers, record 30856464. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30856464
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Isothiocyanates | Major topic |
| Microglia | Major topic |
| Proto-Oncogene Proteins c-akt | Major topic |
| Animals | |
| Anti-Inflammatory Agents, Non-Steroidal | |
| Behavior, Animal | |
| Cells, Cultured | |
| Chromones | |
| Cytokines | |
| Dose-Response Relationship, Drug | |
| Inflammation | |
| Lipopolysaccharides | |
| Male | |
| Mice, Inbred C57BL | |
| Morpholines | |
| Prefrontal Cortex | |
| Signal Transduction | |
| Sulfoxides |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42848270 | Kinetics and mechanisms in lipopolysaccharide-induced neuroinflammation: a framework for phytochemicals screening. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42848270 | PubMed |
| 42650879 | p21 (CDKN1A) Is the Major Driver of Sulforaphane-Mediated Reduction in SAMHD1 T592 Phosphorylation in Macrophages. | Biomolecules | 2026 | https://conductscience.org/library/papers/42650879 | PubMed |
| 41837504 | Targeting the mTOR Pathway with Natural Products: A Potential Therapeutic Approach for Autism Spectrum Disorders. | Curr Neuropharmacol | 2026 | https://conductscience.org/library/papers/41837504 | PubMed |
| 40722922 | Glucosinolate Metabolites and Brain Health: An Updated Review on Their Potential Benefits in Neurodegenerative, Neurodevelopmental, and Psychiatric Disorders. | Antioxidants (Basel) | 2025 | https://conductscience.org/library/papers/40722922 | PubMed |
| 38927376 | Anti-Inflammatory Therapeutic Mechanisms of Isothiocyanates: Insights from Sulforaphane. | Biomedicines | 2024 | https://conductscience.org/library/papers/38927376 | PubMed |
| 38519640 | Genetic contribution to microglial activation in schizophrenia. | Mol Psychiatry | 2024 | https://conductscience.org/library/papers/38519640 | PubMed |
| 35370703 | KRIBB11: A Promising Drug that Promotes Microglial Process Elongation and Suppresses Neuroinflammation. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/35370703 | PubMed |
| 34581988 | Gliotoxicity and Glioprotection: the Dual Role of Glial Cells. | Mol Neurobiol | 2021 | https://conductscience.org/library/papers/34581988 | PubMed |
| 31934839 | Evaluation of Anti-inflammatory Nutraceuticals in LPS-induced Mouse Neuroinflammation Model: An Update. | Curr Neuropharmacol | 2020 | https://conductscience.org/library/papers/31934839 | PubMed |
| 31409554 | The isothiocyanate sulforaphane inhibits mTOR in an NRF2-independent manner. | Phytomedicine | 2021 | https://conductscience.org/library/papers/31409554 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30856464
GET https://conductscience.org/api/papers/v1/30856464/authors